SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-072993
Filing Date
2020-03-13
Accepted
2020-03-13 16:47:50
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d856201ds3.htm S-3 314493
2 EX-4.2 d856201dex42.htm EX-4.2 298600
3 EX-4.4 d856201dex44.htm EX-4.4 96993
4 EX-4.5 d856201dex45.htm EX-4.5 98887
5 EX-4.6 d856201dex46.htm EX-4.6 87291
6 EX-5.1 d856201dex51.htm EX-5.1 25005
7 EX-23.1 d856201dex231.htm EX-23.1 2284
8 GRAPHIC g856201dsp158.jpg GRAPHIC 11087
9 GRAPHIC g856201g50c16.jpg GRAPHIC 51277
  Complete submission text file 0001193125-20-072993.txt   1010745
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237171 | Film No.: 20713459
SIC: 2834 Pharmaceutical Preparations